Heart | Page 97 of 208 | SpiritIndia.com

Heart Disease :: Parents who live long pass on lower risk of cardiovascular disease

Researchers from the long-standing Framingham Heart Study (FHS), a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, report that people whose parents live longer were more likely to avoid developing high blood pressure, high cholesterol, and other risk factors for cardiovascular disease in middle age than their peers whose parents died younger. They also found that the risk factor advantages persisted over time.

Breast Cancer :: FDA approves Glaxo’s Tykerb for advanced breast cancer patients

The US Food and Drug Administration (FDA) approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

Stem Cell :: Chemical cues turn embryonic stem cells into cerebellar neurons

In order to differentiate and specialize, stem cells require very specific environmental cues in a very specific order, and scientists have so far been unable to prod them to go through each of the necessary steps. But now, for the first time, a study in mice by Rockefeller University scientists shows that embryonic stem cells implanted in the brain appear to develop into fully differentiated granule neurons, the most plentiful neuron in the cerebellum.

Heart Attack :: Due to cost, heart attack patients often avoid follow-up care and medication

A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine.

Heart Attack :: Heart attack patients with financial barriers have poorer recovery and quality of life

About one in five heart attack patients report having financial barriers to health care services, and these patients are more likely to have a lower quality of life and increased rate of rehospitalization, according to a study in the March 14 issue of JAMA, a theme issue on access to care.

Childbirth :: Emergency Medicaid for immigrants goes to childbirth

An analysis of state Emergency Medicaid spending contradicts assumptions about emergency care provided to recent immigrants, researchers from the University of North Carolina at Chapel Hill and the Carolinas Center for Medical Excellence have found.

Obese :: Obese patients run higher risk of post-operative complications

Obese patients have a significantly higher risk of complications following surgery, including heart attack, wound infection, nerve injury and urinary tract infection, according to a new study from researchers at the University of Michigan Health System.

Heart :: Schering-Plough announces clinical trial results for oral thrombin receptor antagonist

Schering-Plough Corporation announced today that results of the Phase II trial of its novel oral thrombin receptor antagonist (TRA) SCH 530348 will be presented at the 2007 annual Scientific Sessions of the American College of Cardiology (ACC.07)/Innovation in Intervention (i2) Summit, March 24-27 in New Orleans.

Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients

Patients with heart failure who received the heart medication carvedilol suffered fewer heart attacks and strokes and were less likely to die of these and other vascular events than patients prescribed another beta blocker, metoprolol tartrate, according to a retrospective analysis of COMET (the Carvedilol or Metoprolol European Trial) published in the March 6th issue of The Journal of the American College of Cardiology.

Trans Fats :: Quick Serve Restaurant Roundtable agrees to work on reducing trans fats

A Roundtable of Australian Quick Serve Restaurant industry representatives agreed to a September timetable to draft plans to remove artificial trans fats from their products.